colforsin has been researched along with am-356 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyle, JP; Holland, M; John Challiss, RA; Standen, NB | 1 |
| Adra, CN; Shimoda, LM; Small-Howard, AL; Turner, H | 1 |
2 other study(ies) available for colforsin and am-356
| Article | Year |
|---|---|
Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle.
Topics: Adenylyl Cyclase Inhibitors; Animals; Arachidonic Acids; Carotid Arteries; Colforsin; Cyclic AMP; GTP-Binding Proteins; In Vitro Techniques; Male; Muscle Relaxation; Muscle Tonus; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug | 1999 |
Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.
Topics: Adenylyl Cyclases; Animals; Arachidonic Acids; Camphanes; Cell Line; Colforsin; Cyclic AMP; Cytosol; Down-Regulation; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Indoles; Ligands; Mast Cells; Morpholines; Pertussis Toxin; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction; Time Factors; Transcription, Genetic; Up-Regulation | 2005 |